At least 90% of OI patients have autosomal dominant mutations in COL1A1 or COL1A2 genes, while the minority of the patients had other mutations that affect structural integrity of the skeleton [2,3]. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.